He, Shun
Kahles, Florian
Rattik, Sara
Nairz, Manfred
McAlpine, Cameron S.
Anzai, Atsushi
Selgrade, Daniel
Fenn, Ashley M.
Chan, Christopher T.
Mindur, John E.
Valet, Colin
Poller, Wolfram C.
Halle, Lennard
Rotllan, Noemi
Iwamoto, Yoshiko
Wojtkiewicz, Gregory R.
Weissleder, Ralph
Libby, Peter
Fernández-Hernando, Carlos
Drucker, Daniel J.
Nahrendorf, Matthias
Swirski, Filip K.
Article History
Received: 1 December 2017
Accepted: 5 December 2018
First Online: 30 January 2019
Competing interests
: The General Hospital Corporation has filed a US patent application 62/771,668 with the US Patent and Trademark office entitled ‘Targeting intraepithelial leukocytes for treatment of cardiometabolic diseases’, which names F.K.S. and S.H. as inventors. D.J.D. has served as an advisor or consultant to Intarcia, Forkhead Biopharmaceuticals Inc., Kallyope Inc., Merck Research Laboratories, Pfizer Inc., Novo Nordisk Inc. and Zafgen Inc. Mount Sinai receives funding from GSK, Merck and Novo Nordisk for GLP-1-related studies in the Drucker laboratory.